← Back to Zynova OncoAtlas

Beta Evaluation

Evidence & Validation Roadmap

Zynova OncoAtlas is in active R&D and beta evaluation. The platform is not positioned as a validated diagnostic or treatment-decision system; it is designed as clinical decision-support infrastructure that makes case preparation, data structuring, and pre-decision review more measurable.

This section does not claim clinical performance. Zynova OncoAtlas is in active R&D and beta evaluation; all outputs require physician verification.
Pilot measurement area

Report extraction

Structured data extraction from clinical documents is intended to be compared against physician review.

Pilot measurement area

Missing critical data detection

Pre-decision fields such as stage, biomarkers, ECOG, and prior treatment history are made visible for review.

Pilot measurement area

Trial shortlisting relevance

The quality of converting open trial records into meaningful case-aware shortlists is evaluated.

Pilot measurement area

Physician review time

Changes in case-preparation and report-review time are intended to be measured during pilot use.

Pilot roadmap

  1. Define pilot scope together with the institution
  2. Compare clinical document extraction outputs against physician review
  3. Measure missing critical data detection and trial-shortlist quality
  4. Improve safety and boundary control through institutional feedback

Türkçe özet

Zynova OncoAtlas aktif Ar-Ge ve beta değerlendirme aşamasındadır. Klinik performans iddiası sunmak yerine; veri çıkarımı, eksik kritik veri tespiti, trial kısa liste ilgililiği ve hekim inceleme süresi gibi pilot metrikleri şeffaf biçimde izlemeyi hedefler.

Bu bölüm klinik performans iddiası değildir. Zynova OncoAtlas aktif Ar-Ge ve beta değerlendirme aşamasındadır; tüm çıktıların hekim tarafından doğrulanması gerekir.